Propel Bio Management, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Propel Bio Management, Llc disclosed 23 stock positions valued at approximately $191.09M as of quarter-end June 30, 2026. The largest holdings include PLAINS GP HOLDINGS LP-CL, ACHIEVE LIFE SCIENCES INC, and CORCEPT THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 23
- Portfolio Value
- $191.09M
Holdings by Sector
Propel Bio Management, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| PLAINS GP HOLDINGS LP-CL | PAGP | Energy | 16.16% | 1,272,360 | - | - | $30,880,177 |
| ACHIEVE LIFE SCIENCES INC | ACHV | Healthcare | 13.79% | 4,034,018 | +247,593 | +6.54% | $26,342,138 |
| CORCEPT THERAPEUTICS INC | CORT | Healthcare | 6.21% | 136,499 | -11,329 | -7.66% | $11,868,588 |
| PHATHOM PHARMACEUTICALS I | PHAT | Healthcare | 5.96% | 1,050,358 | +209,086 | +24.85% | $11,396,384 |
| DELCATH SYSTEMS INC | DCTH | Healthcare | 5.74% | 871,460 | -108,238 | -11.05% | $10,971,681 |
| MILESTONE PHARMACEUTICALS | MIST | Healthcare | 5.21% | 7,429,590 | +3,311,269 | +80.40% | $9,955,651 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 4.24% | 573,086 | -168,963 | -22.77% | $8,109,167 |
| KYVERNA THERAPEUTICS INC | KYTX | Healthcare | 4.12% | 883,198 | +238,777 | +37.05% | $7,869,294 |
| ABEONA THERAPEUTICS INC | ABEO | Healthcare | 3.18% | 983,070 | -346,829 | -26.08% | $6,075,373 |
| AQUESTIVE THERAPEUTICS IN | AQST | Healthcare | 3.14% | 1,442,397 | +731,409 | +102.87% | $6,000,372 |
| SAB BIOTHERAPEUTICS INC | SABS | Healthcare | 2.20% | 1,076,578 | +63,788 | +6.30% | $4,198,654 |
| ORCHESTRA BIOMED HOLDINGS | OBIO | Healthcare | 2.02% | 896,701 | - | - | $3,869,265 |
| CELLDEX THERAPEUTICS INC | CLDX | Healthcare | 2.02% | 103,695 | -27,669 | -21.06% | $3,858,491 |
| ZEVRA THERAPEUTICS INC | ZVRA | Healthcare | 1.90% | 253,544 | -28,874 | -10.22% | $3,635,821 |
| OCULAR THERAPEUTIX INC | OCUL | Healthcare | 1.84% | 357,966 | -24,409 | -6.38% | $3,515,226 |
| 4D MOLECULAR THERAPEUTICS IN | FDMT | Healthcare | 1.76% | 252,654 | -127,766 | -33.59% | $3,360,298 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 1.57% | 1,115,538 | +194,081 | +21.06% | $3,000,797 |
| EYEPOINT INC | EYPT | Healthcare | 1.43% | 191,745 | -24,080 | -11.16% | $2,741,954 |
| SILENCE THERAPEUTICS PLC | SLN | Healthcare | 1.10% | 191,733 | +191,733 | +100.00% | $2,105,228 |
| LEONABIO INC | LONA | Other | 0.72% | 149,279 | - | - | $1,371,874 |
| MAZE THERAPEUTICS INC | MAZE | Other | 0.68% | 43,798 | - | - | $1,306,932 |
| CORVUS PHARMACEUTICALS INC | CRVS | Healthcare | 0.55% | 70,380 | -15,411 | -17.96% | $1,051,477 |
| SAGIMET BIOSCIENCES INC-A | SGMT | Healthcare | 0.51% | 125,878 | +125,878 | +100.00% | $973,037 |
Showing 23 of 23 holdings in the latest reporting period.